Neuland Laboratories Limited (NSE:NEULANDLAB)
16,887
-108 (-0.64%)
At close: Dec 5, 2025
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 216.87 billion as of December 5, 2025. Its market cap has increased by 12.50% in one year.
Market Cap
216.87B
Enterprise Value
217.83B
Revenue
15.33B
Ranking
n/a
PE Ratio
90.31
Stock Price
16,887.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 216.87B, an increase of 64,609.79%. That is a compound annual growth rate of 29.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,331.52B |
| Divi's Laboratories | 1,718.51B |
| Cipla | 1,228.46B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |